Dr. Goy on Developments in the Field of Immunology

Andre Goy, MD
Published Online: Wednesday, August 14, 2013
Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, comments on the recent developments in fighting cancer with the immune system.

The effort to harness the immune system to fight cancers cells has had some success, though little has translated into lasting benefit. Recently, the development of immunology has focused on unleashing T cells and promoting their antitumor effect.

Immunology research has focused, among other things, on generating chimeric antigen T cells and developing monoclonal antibodies to unleash T cells. The oncology community, Goy says, believes that using the immune system is promising and could translate into great benefit for patients.

Online CME Activities
Free CME from PER
Cardiology Review/CME Reviews: Volume 31, Number 2
Community Practice Connections: 19th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma
Addressing Disparities in Care Specific to Patients With Lung Cancer: Health Literacy
Addressing Disparities in Care Specific to Patients With Lung Cancer: Patient Cases
More Reading
$auto_registration$